Author:
Castellone Maria Domenica,Vecchio Giancarlo
Publisher
Springer International Publishing
Reference155 articles.
1. Mazzaferri EL (1993) Management of a solitary thyroid nodule. N Engl J Med 328:553–559
2. Kondo T, Ezzat S, Asa SL (2006) Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292–306
3. Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont J et al (1995) Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3′,5′-monophosphate and inositol phosphate-Ca2+ cascades. Mol Endocrinol 9:725–733
4. Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 83:2638–2648
5. Gimm O (2001) Thyroid cancer. Cancer Lett 163:143–156